JVRS-100, a seasonal influenza vaccine for the elderly from Juvaris BioTherapeutics, Inc is currently undergoing human studies. Juvaris BioTherapeutics, Inc has begun enrolling patients in a Phase 2 clinical trial of its lead compound, JVRS-100, as an adjuvant for seasonal influenza vaccines in the elderly population. “There is a significant need to ...

Provenge (sipuleucel-T), a vaccine to treat prostate cancer from Dendreon Corporation may reach market within a year's time.

Daiichi Sankyo-controlled Ranbaxy Laboratories has sold its Vietnam business, as part of the company's ongoing restructuring operations. Ranbaxy may soon sell another of its business soon as it wants to divest of some of its loss making businesses, Ranbaxy CEO and MD Atul Sobti has stated. “We have divested the Vietnam operations ...

Indian generic major Wockhardt announced a 2.2 percent growth in consolidated sales revenues to stand at Rs 923 crore (about $197.25 million) for the third quarter ended September 30, 2009 over the corresponding quarter of 2008.

India' Lupin has approached the US Food & Drug Administration (US FDA) asking not to approve generic versions of antibiotic cefixime in oral suspension from companies including Orchid Pharma unless their products meet ``the same standards that the Lupin drug had to meet'', reports said.